Come up with a name for your new list and we'll add to it:
Pulse Therapeutics raised a round of funding on October 21, 2010. Investors include
St. Louis Arch Angels.
Pulse Therapeutics has developed a medical device designed to significantly improve the conveyance of physician-selected agents, like tPA, in the emergency department (ED). By destroying clots earlier…